{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:17:28Z","timestamp":1779308248812,"version":"3.51.4"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>BK virus-associated nephropathy (BKVN) is a viral complication after kidney transplantation and an important cause of graft dysfunction and loss. Its impact on HIV-positive kidney transplant recipients (KTRs), who are at increased risk for opportunistic infections, remains poorly understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>This single-center case series in South Africa describes BKVN incidence and outcomes in HIV-positive KTRs who received kidneys from HIV-positive donors between 2008 and 2025. A screening protocol and schedule were implemented in 2021, and BKVN was classified as possible, probable, or presumptive according to The Second International Consensus Guidelines.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      Over the study period, there were 63 KTRs and 34 donors; 2 recipients with primary graft failure were excluded. The remaining 61 recipients had a median age of 40 y, 54% were male, and 93% were of Black African ethnicity. Median CD4 count at transplantation was 439 cells\/mm\n                      <jats:sup>3<\/jats:sup>\n                      , and all KTRs had suppressed HIV viral load on antiretroviral therapy. HIV-associated nephropathy was the most common cause of end-stage kidney disease. Hypertension was prevalent (89%), and one-third had a history of treated tuberculosis. All patients received antithymocyte globulin induction at transplant. Seventeen recipients had no BKVN screening data, 36 maintained negative BK viral loads, while 8 developed BK polyomavirus viremia and\/or viruria. Of these, 2 (3%) had polymerase chain reaction-confirmed viremia, and 6 (10%) met criteria for possible (n\u2005=\u20051), probable (n\u2005=\u20052), or presumptive BKVN (n\u2005=\u20053). BK polyomavirus viremia and\/or viruria occurred either within 6 mo or between 1 and 2 y posttransplant. Management consisted of reducing immunosuppression. Possible and probable cases (5%) maintained functioning grafts. All 3 (5%) presumptive cases had biopsy-proven disease, with one resulting in graft loss (1.6%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Despite limited resources and delayed routine screening, the BKVN incidence was low (5%), and most affected recipients achieved viral control and preserved graft function.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001936","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:01:09Z","timestamp":1779307269000},"page":"e1936","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Incidence of BK Virus in HIV-positive Kidney Transplant Recipients: Case Series From South Africa"],"prefix":"10.1097","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5599-3606","authenticated-orcid":false,"given":"Laurie","family":"Bertels","sequence":"first","affiliation":[{"name":"Department of Surgery, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4213-2522","authenticated-orcid":false,"given":"Kathryn","family":"Manning","sequence":"additional","affiliation":[{"name":"Department of Surgery, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew D.","family":"Redd","sequence":"additional","affiliation":[{"name":"Division of Intramural Research, NIAID, NIH, Bethesda, MD."},{"name":"Department of Medicine, Johns Hopkins University, Baltimore, MD."},{"name":"Faculty of Health Sciences, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zunaid","family":"Barday","sequence":"additional","affiliation":[{"name":"Department of Medicine, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elmi","family":"Muller","sequence":"additional","affiliation":[{"name":"Department of Surgery, Groote Schuur Hospital, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa."},{"name":"Faculty of Medicine and Health Sciences, Stellenbosch University, Stellenbosch, South Africa."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"R1-20260520","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/TP.0000000000003485","article-title":"Kidney transplantation in HIV-positive patients: current practice and management strategies.","volume":"105","author":"Muller","year":"2021","journal-title":"Transplantation"},{"key":"R2-20260520","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1111\/ajt.16185","article-title":"COVID-19 and kidney transplantation: results from the TANGO International Transplant Consortium.","volume":"20","author":"Cravedi","year":"2020","journal-title":"Am J Transplant"},{"key":"R3-20260520","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/microorganisms12010065","article-title":"BKPyV DNAemia in kidney transplant recipients undergoing regular screening: a single-centre cohort study.","volume":"12","author":"Rasmussen","year":"2023","journal-title":"Microorganisms"},{"key":"R4-20260520","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ekir.2022.12.020","article-title":"Incidence, risk factors, and outcomes of kidney transplant recipients with BK polyomavirus-associated nephropathy.","volume":"8","author":"Gately","year":"2023","journal-title":"Kid Inter Reports"},{"key":"R5-20260520","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.kint.2025.06.014","article-title":"A systematic literature review and meta-analysis evaluated modifiable risk factors for the development of BK polyoma virus-associated complications.","volume":"108","author":"Eder","year":"2025","journal-title":"Kidney Int"},{"key":"R6-20260520","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/v14081616","article-title":"BK virus nephropathy in kidney transplantation: a state-of-the-art review.","volume":"14","author":"Kant","year":"2022","journal-title":"Viruses"},{"key":"R7-20260520","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1097\/TP.0000000000004976","article-title":"The second international consensus guidelines on the management of BK polyomavirus in kidney transplantation.","volume":"108","author":"Kotton","year":"2024","journal-title":"Transplantation"},{"key":"R8-20260520","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.transproceed.2024.02.024","article-title":"Incidence and outcomes of BK virus nephropathy in kidney transplant recipients with steroid-free maintenance immunosuppression.","volume":"56","author":"Garcia-Lopez","year":"2024","journal-title":"Transplant Proc"},{"key":"R10-20260520","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMc1903013","article-title":"Longer-term outcomes of HIV-positive\u2013to\u2013HIV-positive renal transplantation.","volume":"381","author":"Selhorst","year":"2019","journal-title":"N Engl J Med"},{"key":"R11-20260520","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/TP.0000000000005271","article-title":"Clinical and histopathological findings in HIV-positive to HIV-positive kidney transplant recipients.","volume":"109","author":"Wearne","year":"2025","journal-title":"Transplantation"},{"key":"R12-20260520","doi-asserted-by":"crossref","first-page":"e70333","DOI":"10.1111\/ctr.70333","article-title":"Long-term outcomes of BK viremia in kidney transplant recipients.","volume":"39","author":"Tandukar","year":"2025","journal-title":"Clin Transplant"},{"key":"R13-20260520","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12879-023-08043-z","article-title":"Characteristics, risk factors and outcome of BKV nephropathy in kidney transplant recipients: a case-control study.","volume":"23","author":"Gras","year":"2023","journal-title":"BMC Infect Dis"},{"key":"R14-20260520","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1097\/TP.0000000000002414","article-title":"Epidemiology of and risk factors for BK polyomavirus replication and nephropathy in pediatric renal transplant recipients: an international CERTAIN registry study.","volume":"103","author":"H\u00f6cker","year":"2019","journal-title":"Transplantation"},{"key":"R15-20260520","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/TP.0b013e31819cc383","article-title":"An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States.","volume":"87","author":"Dharnidharka","year":"2009","journal-title":"Transplantation"},{"key":"R16-20260520","first-page":"12","article-title":"BK virus nephropathy in renal transplantation: case series and review of the literature.","volume":"29","author":"Balo\u011flu","year":"2020","journal-title":"Curr Status Renal Rep Therapy Turkey"},{"key":"R17-20260520","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3390\/v13030476","article-title":"High incidence and early onset of urinary tract cancers in patients with BK polyomavirus associated nephropathy.","volume":"13","author":"Li","year":"2021","journal-title":"Viruses"},{"key":"R18-20260520","doi-asserted-by":"crossref","first-page":"e0269990","DOI":"10.1371\/journal.pone.0269990","article-title":"Risk factors for graft loss and death among kidney transplant recipients: a competing risk analysis.","volume":"17","author":"Pinto-Ramirez","year":"2022","journal-title":"PLoS One"},{"key":"R19-20260520","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/CM9.0000000000000085","article-title":"Prognosis of BK polyomavirus nephropathy: 10-year analysis of 133 renal transplant recipients at a single center.","volume":"132","author":"Chen","year":"2019","journal-title":"Chin Med J (Engl)"},{"key":"R20-20260520","article-title":"342.2: ATG dose is associated with CMV viremia but not BK viremia in living donor kidney transplants.","volume":"108","author":"Ebru","year":"2024","journal-title":"Transplantation"},{"key":"R21-20260520","doi-asserted-by":"crossref","first-page":"704","DOI":"10.12659\/AOT.910483","article-title":"Risk factors of acute rejection in patients with BK nephropathy after reduction of immunosuppression.","volume":"23","author":"Baek","year":"2018","journal-title":"Ann Transplant"},{"key":"R22-20260520","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3346\/jkms.2013.28.12.1711","article-title":"Impact of combined acute rejection on BK virus-associated nephropathy in kidney transplantation.","volume":"28","author":"Kim","year":"2013","journal-title":"J Korean Med Sci"},{"key":"R23-20260520","doi-asserted-by":"crossref","first-page":"e13194","DOI":"10.1111\/ctr.13194","article-title":"De novo donor-specific antibody following BK nephropathy: the incidence and association with antibody-mediated rejection.","volume":"32","author":"Cheungpasitporn","year":"2018","journal-title":"Clin Transplant"},{"key":"R24-20260520","doi-asserted-by":"crossref","first-page":"e14791","DOI":"10.1111\/petr.14791","article-title":"BK polyomavirus DNAemia, allograft rejection, and de novo donor-specific antibodies after lowering target tacrolimus levels in pediatric kidney transplant recipients.","volume":"28","author":"Huang","year":"2024","journal-title":"Pediatr Transplant"},{"key":"R25-20260520","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1681\/ASN.2014010119","article-title":"Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies.","volume":"26","author":"Sawinski","year":"2015","journal-title":"J Am Soc Nephrol"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001936","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:01:12Z","timestamp":1779307272000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001936"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001936","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"2025-12-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}